Exclusive: UnitedHealth's artery-screening gold mine

Plus: Trump keeps losing his train of thought. Cognitive experts have theories about why

August 7, 2024 Check out STAT+

Sponsored By

JIM WATSON/AFP via Getty Images Trump keeps losing his train of thought. Cognitive experts have theories about why Increased tangentiality, all-or-nothing-thinking, and unusually simple sentence structure are called 'suggestive' of cognitive decline. By Olivia Goldhill STAT+ | Novo Nordisk pulls filings for Wegovy in heart failure as it waits for cardiovascular outcomes data The company plans to reapply next year when it has more data on complications such as hospitalizations and cardiovascular-related deaths. By Elaine Chen and Andrew Joseph STAT+ | The race to build better CRISPR delivery vehicles is heating up Scientists are looking beyond LNPs and viruses, rummaging around other corners of biology for solutions to the CRISPR delivery problem. By Megan Molteni STAT+ | How UnitedHealth turned a questionable artery-screening program into a gold mine Patients were screened with a thinly tested medical device, dramatically boosting Medicare Advantage payments. By Casey Ross, Lizzy Lawrence, Bob Herman, and Tara Bannow STAT+ | CVS removes top Aetna leader as higher medical costs eat further into profits Facing rising expenses for Aetna's Medicare Advantage plan, CVS removed the top executive who'd overseen the MA expansion, lowered 2024 profit estimates. By Bob Herman Why Tim Walz' record on Covid-19 will be a hot-button issue in 2024 Kamala Harris' VP pick Tim Walz enacted stringent Covid-19 mandates as governor of Minnesota. Trump will likely make those policies a target. By Sarah Owermohle Adobe A new drug for glioma means a windfall for Agios Good morning. Today's biotech news includes Novo Nordisk earnings, a windfall drug for Agios, and Illumina's strategy update. By Elaine Chen STAT+ | FDA scolds Bristol Myers over a misleading website for a cancer treatment "The calculations … are not supported by the data cited" in the study touted on the website, the FDA warned Bristol Myers. By Ed Silverman STAT+ | Supply issues weigh on Novo Nordisk as drugmaker stumbles with quarterly report Novo executives said they are improving the supply of its blockbuster obesity and diabetes medications, which should increase sales. By Andrew Joseph FABRICE COFFRINI/AFP via Getty Images WHO to convene panel to determine whether mpox outbreak is a public health emergency The outbreak began in the Democratic Republic of the Congo but has spread recently to at least three other neighboring countries. By Helen Branswell

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser